MedPath

Eye movement desensitization and reprocessing (EMDR): efficacy in improving clinical, neuropsychological, and quality of life in women victims of violence

Not Applicable
Completed
Conditions
Women exposed to gender-based violence who show symptoms of anxiety, depression and post-traumatic stress, in addition to low performance in cognitive functioning, or that limits performance in daily life
Mental and Behavioural Disorders
Registration Number
ISRCTN85117262
Lead Sponsor
Campus Grupal Foundation
Brief Summary

2023 Other publications in https://doi.org/10.1089/whr.2023.0019 Clinical Neuropsychological Profile and Quality of Life in Women Who Have Suffered Gender-Based Violence (added 14/12/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
120
Inclusion Criteria

1. Exposed to gender violence (physical, psychological and/or sexual)
2. Between 18 and 50 years of age
3. Signed the informed consent form

Exclusion Criteria

1. Intelligence quotient (IQ) lower than 70
2. History of brain damage
3. History of severe neurological or psychiatric illness
4. History of toxic consumption
5. Presence of sensory alterations that impeded the performance of the tests

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment:<br>Neuropsychological functioning was measured using the following tests:<br>1. The Rey Auditory Verbal Learning Test RAV LT.<br>2. Coding - subtest WAIS IV.<br>3. Test D2. measures selective and sustained attention.<br>4. Trail Making Test, part A (TMT-A) and part B (TMT-B).<br>5. Stroop Test. An instrument that assesses complex attention.<br>6. Phonological Verbal Fluency Test PVFT.<br>7. Semantic Verbal Fluency Test SVFT. Assesses the ability to retrieve stored semantic information.<br>
Secondary Outcome Measures
NameTimeMethod
Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment:<br>1. Gender violence - Questionnaire on violence<br>2. Anxiety and depression are measured using the Hospital Anxiety and Depression Scale HADS scale<br>3. Posttraumatic Stress Disorder is measured using the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)<br>4. Quality of Life is measured using GENCAT Scale
© Copyright 2025. All Rights Reserved by MedPath